inova pharmaceuticals

Private

Last Round

Buyout/LBO

Oct 31, 2022

Est. Valuation

$2B

Total Funding Raised

$1.62B

Company Overview

Manufacturer and marketer of prescription and over-the-counter medicines.

Historical view of private secondary pricing and transaction trends.

Book a demo to explore historical pricing and secondary transactions.

For institutional investors. Book with your work email.

Proprietary index based on bid/ask volume and sentiment.

Track how buyer interest and sentiment changes over time.

For institutional investors. Book with your work email.

Compare inova pharmaceuticals with similar companies based on industry and business-model similarity.

No public comparables are available for inova pharmaceuticals. Request access to learn about comparables coverage.

For institutional investors. Book with your work email.

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Buyout/LBO	Oct 31, 2022	Book a demo	Book a demo	Book a demo	Book a demo
Private Equity	Sep 29, 2017	Book a demo	Book a demo	Book a demo	Book a demo
M&A	Nov 20, 2011	Book a demo	Book a demo	Book a demo	Book a demo

For institutional investors. Book with your work email.

Explore SEC and related filing metadata, where available.

inova pharmaceuticals filings preview — column headings only; records require access
Type	Date	Amount Offered	Amount Sold	Filing	Pages	Download

Filing documents are not displayed on this public page. Request access to learn about available coverage.

For institutional investors. Book with your work email.

Headquarters—

Year Founded2006

Last FundingOct 31, 2022

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

For institutional investors. Book with your work email.

See something wrong or outdated?